Bluepharma was awarded the COTEC 2021 Innovative Statute, in recognition of its high standards of financial soundness, innovation skills and economic performance. With the award of this seal, the pharmaceutical firm is classified as a company of high competitive potential and growth.
The Innovative Statute COTEC 2021 is an initiative of COTEC Portugal, a Portuguese business association for the promotion of innovation and business technological cooperation, which aims to distinguish national companies with high innovation performance. This is also a way to contribute to the public recognition of organizations that are good examples of value creation for the country.
"The awarding of this prestigious status, precisely in the year in which we mark 20 years of history in the pharmaceutical industry, is, for us, an immense recognition of the rigorous work we have been carrying out over these two decades. It fills us with pride to feel the trust they place in us," says Paulo Barradas Rebelo, President of Bluepharma.
Through this initiative Bluepharma will now be able to benefit from access to a network of partners, enhancing the benefits of the distinction to ensure better financing conditions, which will contribute to its continued development and, consequently, added value to the national economy.